INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 58 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $307,726 | +31.6% | 1,461,881 | +0.0% | 0.00% | – |
| Q1 2023 | $233,845 | -73.4% | 1,461,529 | -7.8% | 0.00% | – |
| Q4 2022 | $879,909 | -67.6% | 1,585,423 | -30.5% | 0.00% | – |
| Q3 2022 | $2,714,000 | +86.1% | 2,280,647 | -1.1% | 0.00% | – |
| Q2 2022 | $1,458,000 | -80.5% | 2,305,486 | -64.9% | 0.00% | – |
| Q1 2022 | $7,489,000 | -50.1% | 6,569,410 | -1.5% | 0.00% | – |
| Q4 2021 | $15,001,000 | -26.7% | 6,667,503 | +11.4% | 0.00% | -100.0% |
| Q3 2021 | $20,464,000 | +13.3% | 5,983,489 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $18,065,000 | +178.8% | 6,041,344 | +201.2% | 0.00% | – |
| Q1 2021 | $6,480,000 | +212.9% | 2,006,016 | +105.4% | 0.00% | – |
| Q4 2020 | $2,071,000 | +82.3% | 976,446 | +0.6% | 0.00% | – |
| Q3 2020 | $1,136,000 | +29.4% | 970,698 | +0.0% | 0.00% | – |
| Q2 2020 | $878,000 | +8.4% | 970,641 | +0.3% | 0.00% | – |
| Q1 2020 | $810,000 | -13.0% | 967,357 | -0.2% | 0.00% | – |
| Q4 2019 | $931,000 | -6.8% | 969,507 | -0.0% | 0.00% | – |
| Q3 2019 | $999,000 | -43.0% | 969,972 | -0.4% | 0.00% | – |
| Q2 2019 | $1,753,000 | -4.2% | 974,017 | +0.1% | 0.00% | – |
| Q1 2019 | $1,829,000 | +58.4% | 973,163 | -0.6% | 0.00% | – |
| Q4 2018 | $1,155,000 | -56.4% | 978,748 | +0.1% | 0.00% | – |
| Q3 2018 | $2,651,000 | +42.8% | 978,123 | +0.6% | 0.00% | – |
| Q2 2018 | $1,857,000 | -7.1% | 972,253 | +2.1% | 0.00% | – |
| Q1 2018 | $1,999,000 | +2.8% | 951,901 | -0.6% | 0.00% | – |
| Q4 2017 | $1,944,000 | +44.4% | 957,841 | -5.4% | 0.00% | – |
| Q3 2017 | $1,346,000 | -6.2% | 1,012,361 | +10.8% | 0.00% | – |
| Q2 2017 | $1,435,000 | -85.2% | 913,460 | -69.6% | 0.00% | -100.0% |
| Q1 2017 | $9,693,000 | +8875.0% | 3,001,051 | +3620.8% | 0.00% | – |
| Q4 2016 | $108,000 | -35.7% | 80,657 | -25.3% | 0.00% | – |
| Q3 2016 | $168,000 | +17.5% | 107,958 | 0.0% | 0.00% | – |
| Q2 2016 | $143,000 | +741.2% | 107,958 | +3199.4% | 0.00% | – |
| Q1 2016 | $17,000 | +70.0% | 3,272 | +146.4% | 0.00% | – |
| Q4 2015 | $10,000 | -71.4% | 1,328 | -67.8% | 0.00% | – |
| Q3 2015 | $35,000 | +150.0% | 4,128 | +210.8% | 0.00% | – |
| Q2 2015 | $14,000 | -33.3% | 1,328 | -9.4% | 0.00% | – |
| Q1 2015 | $21,000 | -16.0% | 1,465 | 0.0% | 0.00% | – |
| Q4 2014 | $25,000 | +25.0% | 1,465 | 0.0% | 0.00% | – |
| Q3 2014 | $20,000 | +5.3% | 1,465 | 0.0% | 0.00% | – |
| Q2 2014 | $19,000 | +11.8% | 1,465 | -1.8% | 0.00% | – |
| Q1 2014 | $17,000 | -19.0% | 1,492 | 0.0% | 0.00% | – |
| Q4 2013 | $21,000 | -19.2% | 1,492 | 0.0% | 0.00% | – |
| Q3 2013 | $26,000 | -69.0% | 1,492 | -70.9% | 0.00% | – |
| Q2 2013 | $84,000 | – | 5,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |